Sébastien Lacroix-Desmazes

6PUBLICATIONS
25CO-AUTHORS
Humoural immunology and immunochemistryApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 19, 2025
[A new role for antibodies in deep venous thrombosis].

Félicien Triboulet, Boris Lerais, Andy Li

|Apr 09, 2025
Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent states.

Diego Butera, Aster E Pijning, Nathan G Avery

|Sep 05, 2020
Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy.

Shannon L Meeks, Sébastien Lacroix-Desmazes

|Jul 02, 2020
Inhibitors-Recent insights.

Kathleen P Pratt, Valder R Arruda, Sébastien Lacroix-Desmazes

|Jun 03, 2020
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies.

Christian Leborgne, Elena Barbon, Jeffrey M Alexander

|Sep 07, 2018
Catalytic antibodies in patients with systemic lupus erythematosus.

Vandana Pradhan, Pallavi Pandit, Prathamesh Surve

Pageof 1